A virtual (Zoom) and face-to-face meeting in Paris, France
followed by Lunch
Other Logistical information to follow nearer the time
---------------------------------------------------------------------------------------------------------------------------------------------
The 2020 GA meeting which normally takes place in May was postponed to November 4th due to the global pandemic. The November 4th meeting which was virtual saw 20 attendees and lasted an hour as most of the GA mandated task/decisions were addressed by way of votes prior to the meeting. Chaired by Interim Chairman Dr Bernd Friede, the meeting though brief was effective with some key decisions taken as follows:
Some highlights:
- Executive Committee: A new Executive team was endorsed with the 2nd Vice-Chairman becoming the Chairman and Secretary General maintained to ensure continuity
- Non-EU letter of Access Fees: Letter of Access fees and administration fees for non-EU REACH-Like regulations per substance, per legal entity for non-MARA members was established
- Members involvement in Non-EU regulations: MARA members wishing to register substances in non-EU REACH-like regulations will only pay administration fees as they own the data generated by MARA
- Technical update: Three dossiers updated this year lead to a new classification for manganese based UVCB’s
- 2020 Workplan and budget were ratified in Q1, 2020 via round robin votes.
Manganese ores, reduced (EC: 273-748-0; Cas: 69012-49-3)
Submitted in 2010, with no testing proposals, this substance has not undergone any aspect of the REACH evaluation process to date.
So far, the reveiw of the orginal 2010 dossier along side post 2010 ECHA guidance documents on substance ID, has led to a slight change on the SIP/Boundary composition.
New updated 2019 SIP/Boundary composition:
| Component | Silicon Dioxide | Aluminium Oxide | Barium Oxide | Calcium Oxide | Iron & Oxides of Iron | Manganese and oxides of Manganese | ||
|
(% w/w) (Range) |
8.5 (5-10) |
7.5 (5-10) |
0 (0-1) |
3 (1-10) |
8 (5-15) |
50 (45-60) |
While this dossier has not undergone any compliance check request from the ECHA , other UVCB substances in thesame readacross category required significant dossier updates and testing request from ECHA.
In view of the newly generated serrogate data, this dossier has been updated in Q3, 2020. The updated dossier has an updated self classifcation for pre-natal development emanating from the a pre-natal developmental toxicity study on readacross substance FeMn slag. To this end, a new/updated CSR and ES has been generated.
The secretariat therefore encourages all registrants to update their dossiers accordingly. Please request your updated CSR's and ES by contacting reach@manganese.org
Note: Post 2018, the consortium will no longer invoice co-registrants for ECHA requested studies retrospectively. All compliance check related work will require co-registrants to contribute their share before any dossier update work can begin.